Why NeuroDiversion CE—Affirming, Evidence-Based Continuing Education

Why NeuroDiversion

Affirming care isn't the gentle option. It's the accurate one.

We built NeuroDiversion to close the distance between the clients in your office and the training most of us received—on-demand training that's neurodivergent-affirming, evidence-based, and built to use right away.

Neurodivergent-affirming Evidence-based Practice-ready
Two attendees stand together outside the venue at NeuroDiversion, smiling
Two attendees with conference lanyards at the NeuroDiversion evening reception
An attendee in a green velvet coat smiling under the trees at NeuroDiversion
Two attendees holding session notes in the garden at NeuroDiversion

The best practitioners never stop learning.

You didn't choose this work to keep practicing from a model that doesn't fit the people in front of you. Continuing education is how the field keeps up.

We're trying to make it worth the hours again.

The problem

Most training never prepared you for this caseload.

The gap has nothing to do with your competence and everything to do with what graduate school had time to cover. You're seeing more autistic and ADHD clients than at any point in your career—recognition catching up to reality—and the CE meant to close that gap mostly hasn't.

1 in 31

8-year-olds identified autistic in 2022—up from roughly 1 in 150 in 2000.

15.5M

U.S. adults with a current ADHD diagnosis; about half weren't identified until adulthood.

Lowest

Of every condition they treat, therapists rank their autism training last. (~500 surveyed.)

Sources 1  CDC ADDM · 2025 2  CDC MMWR · 2024 3  Lipinski et al. · 2022

Our premise

What we believe

Most of us were trained in a deficit model—neurodivergence as a set of problems to reduce and behaviors to correct. That framing produces worse care. When therapy expects an autistic client to present as neurotypical, the mismatch gets read as resistance, and the work stalls.

Affirming practice begins from a different question: how does this brain actually work, and how should the treatment fit it? This is a more accurate clinical model, and the one your clients have been asking for.

How we build it

We obsess over two things

Whether the clinical content holds up—and whether the experience works for the brain taking it in. Most CE gets the first wrong and skips the second.

The content is rigorous

Independent — No pharmaceutical-industry funding.

NeuroDiversion takes no money from drug manufacturers. Our clinical guidance answers to the evidence, not to anyone selling a prescription.

Reviewed — Vetted by a clinician team.

Every clinical course is reviewed by a team of licensed mental health professionals before release. High-stakes and pharmacology content doesn’t ship without sign-off.

Sourced — Cited to primary research.

Empirical claims are cited on-screen and in a reference list you keep. Where the evidence is still emerging—like RSD—we say so.

The format is built for ND brains

We teach neurodivergent-affirming practice—so it would be strange to deliver it in a wall of three-hour lecture videos. The training is designed for the way your attention actually works.

1
Short, focused videos

Animated and to the point. If you prefer reading or audio format, that’s fine too.

2
Spaced-repetition flashcards

So the material sticks long after the post-test, not just until it.

3
Self-paced and rewatchable

Pause, jump back, and return whenever your focus does.

Sources

1 Shaw KA, et al. MMWR Surveillance Summaries, 2025. CDC ADDM Network—16 sites, 2022 surveillance year.
2 Staley BS, et al. MMWR Morb Mortal Wkly Rep, 2024;73(40):890–895. DOI: 10.15585/mmwr.mm7340a1.
3 Lipinski S, et al. A blind spot in mental healthcare? Autism, 2022;26(6):1509–1521. DOI: 10.1177/13623613211057973.

This is the training we went looking for and couldn’t find. So we built it.

CE courses for licensed clinicians and coaches
NeuroDiversion CE

© 2025 – 2026 NeuroDiversion · Continuing education for affirming clinical practice

NeuroDiversion has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 8133. Programs that do not qualify for NBCC credit are clearly identified. NeuroDiversion is solely responsible for all aspects of the programs.